glp 1 agonist black box warning FDA Says to Drop Suicide From GLP-1 Drug Labels Exploring the Side Effects of

A conversation with a physician about the specific pharmacology of retatrutide cardiovascular effects is prudent before starting treatment

Anti-obesity medications and investigational agents: an Obesity Medicine Association (OMA) clinical practice statement (CPS) 2022

The triple agonist mechanism appears to match or slightly exceed tirzepatide for blood sugar management , likely because the glucagon component, while it can raise blood sugar in isolation, works synergistically with GLP-1 and GIP activation to produce a net positive effect on glucose regulation

Moreover, the SUSTAIN trials, which studied the effects of semaglutide in those with T2DM, also demonstrated significant improvement in risk factors, with a substantial 26% relative reduction in cardiovascular events such as nonfatal myocardial infarction and stroke [13,14,29]

doi: 10.1016/j.jhep.2024.07.006 48

The resulting increase in vagal toe inhibits gastric emptying and gastric acid secretion, subsequently resulting in a delay of gastric emptying, and reduction of glucose absorption (Shaefer et al, 2015)